Robert Elashoff

3.0k total citations
37 papers, 2.2k citations indexed

About

Robert Elashoff is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Rehabilitation. According to data from OpenAlex, Robert Elashoff has authored 37 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pathology and Forensic Medicine, 13 papers in Pulmonary and Respiratory Medicine and 7 papers in Rehabilitation. Recurrent topics in Robert Elashoff's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers), Systemic Sclerosis and Related Diseases (8 papers) and Stroke Rehabilitation and Recovery (7 papers). Robert Elashoff is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers), Systemic Sclerosis and Related Diseases (8 papers) and Stroke Rehabilitation and Recovery (7 papers). Robert Elashoff collaborates with scholars based in United States, Canada and Australia. Robert Elashoff's co-authors include Bruce H. Dobkin, Michael Saulino, Susan J. Harkema, Andrea L. Behrman, Lisa Fugate, Michael D. Scott, Dan Deforge, Ellen R. Gritz, J F Ditunno and H. Barbeau and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Annals of Internal Medicine.

In The Last Decade

Robert Elashoff

37 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Elashoff United States	22	804	557	510	425	369	37	2.2k
Corrado Bernasconi Switzerland	28	1.0k 1.3×	121 0.2×	366 0.7×	308 0.7×	490 1.3×	111	3.3k
Simone Thomas Germany	21	184 0.2×	675 1.2×	347 0.7×	470 1.1×	244 0.7×	67	1.9k
Björn Svensson Sweden	33	354 0.4×	67 0.1×	337 0.7×	232 0.5×	584 1.6×	116	3.9k
Kay E. Wellik United States	20	2.7k 3.3×	140 0.3×	230 0.5×	146 0.3×	133 0.4×	57	4.1k
Leo H. Visser Netherlands	33	826 1.0×	113 0.2×	125 0.2×	240 0.6×	66 0.2×	107	3.8k
Jaime Masjuán Spain	25	384 0.5×	346 0.6×	111 0.2×	135 0.3×	68 0.2×	150	2.6k
Enrique R. Soriano Argentina	29	231 0.3×	135 0.2×	375 0.7×	121 0.3×	956 2.6×	193	4.0k
John G. Hanly Canada	42	1.0k 1.3×	55 0.1×	179 0.4×	506 1.2×	491 1.3×	137	5.8k
Yeşim Kirazlı Türkiye	20	250 0.3×	125 0.2×	284 0.6×	43 0.1×	585 1.6×	51	2.5k
Jennifer M. Weiss United States	32	465 0.6×	181 0.3×	265 0.5×	948 2.2×	14 0.0×	111	3.9k

Countries citing papers authored by Robert Elashoff

Since Specialization

Citations

This map shows the geographic impact of Robert Elashoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Elashoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Elashoff more than expected).

Fields of papers citing papers by Robert Elashoff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Elashoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Elashoff. The network helps show where Robert Elashoff may publish in the future.

Co-authorship network of co-authors of Robert Elashoff

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Elashoff. A scholar is included among the top collaborators of Robert Elashoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Elashoff. Robert Elashoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Volkmann, Elizabeth R., Li Ning, Dinesh Khanna, et al.. (2019). AB0695 LONG-TERM OUTCOMES OF AFRICAN AMERICAN PATIENTS WITH SYSTEMIC SCLEROSIS-RELATED INTERSTITIAL LUNG DISEASE. Annals of the Rheumatic Diseases. 78. 1808–1808. 3 indexed citations

Sim, Minyoung, DP Tashkin, Dhanita Khanna, et al.. (2017). OP0124 Treatment with cyclophosphamide for systemic sclerosis-related interstitial lung disease does not improve survival after 12 years of follow up. Annals of the Rheumatic Diseases. 76. 104–104. 1 indexed citations

Tashkin, Donald P., Michael D. Roth, Philip J. Clements, et al.. (2015). Efficacy and Safety of Mycophenolate (MMF) Vs Oral Cyclophosphamide (CYC) for Treatment of Scleroderma-Interstitial Lung Disease (Ssc-ILD): Results of Scleroderma Lung Study II. CHEST Journal. 148(4). 637A–637A. 4 indexed citations

Volkmann, Elizabeth R., et al.. (2014). OP0275 Development of A Composite Outcome Measure for Systemic Sclerosis-Related Interstitial Lung Disease. Annals of the Rheumatic Diseases. 73. 165–165. 1 indexed citations

Wang, Richard T., Ivana Janković, Ascia Eskin, et al.. (2014). Online Self-Report Data for Duchenne Muscular Dystrophy Confirms Natural History and Can Be Used to Assess for Therapeutic Benefits. PLoS Currents. 6. 27 indexed citations

Roth, Michael D., Chi‐Hong Tseng, Philip J. Clements, et al.. (2011). Predicting Treatment Outcomes And Responder Subsets In Scleroderma-Related Interstitial Lung Disease. A3822–A3822. 2 indexed citations

Goldin, Jonathan, Fereidoun Abtin, David A. Lynch, et al.. (2010). Cyclophosphamide Treatment Versus Placebo In Scleroderma Lung Study Using Total Quantitative Score Of Fibrosis, Ground Glass Opacity, And Honeycomb. A2360–A2360. 1 indexed citations

Khanna, Dinesh, Chi‐Hong Tseng, D.E. Furst, et al.. (2009). Minimally important differences in the Mahler's Transition Dyspnoea Index in a large randomized controlled trial--results from the Scleroderma Lung Study. Lara D. Veeken. 48(12). 1537–1540. 33 indexed citations

Hant, Faye N., A Ludwicka, Hejing Wang, et al.. (2009). Surfactant Protein D and KL-6 as Serum Biomarkers of Interstitial Lung Disease in Patients with Scleroderma. The Journal of Rheumatology. 36(4). 773–780. 137 indexed citations

10.

Ditunno, John F., Hugues Barbeau, Bruce H. Dobkin, et al.. (2007). Validity of the Walking Scale for Spinal Cord Injury and Other Domains of Function in a Multicenter Clinical Trial. Neurorehabilitation and neural repair. 21(6). 539–550. 94 indexed citations

11.

Dobkin, Bruce H., D F Apple, H. Barbeau, et al.. (2006). Weight-supported treadmill vs over-ground training for walking after acute incomplete SCI. Neurology. 66(4). 484–493. 363 indexed citations

12.

Taback, Bret, Steven O’Day, Peter D. Boasberg, et al.. (2004). Circulating DNA Microsatellites: Molecular Determinants of Response to Biochemotherapy in Patients With Metastatic Melanoma. JNCI Journal of the National Cancer Institute. 96(2). 152–156. 53 indexed citations

13.

Dobkin, Bruce H., David F. Apple, Hugues Barbeau, et al.. (2003). Methods for a Randomized Trial of Weight-Supported Treadmill Training Versus Conventional Training for Walking During Inpatient Rehabilitation after Incomplete Traumatic Spinal Cord Injury. Neurorehabilitation and neural repair. 17(3). 153–167. 126 indexed citations

14.

Sartippour, Maryam, David Heber, Liping Zhang, et al.. (2002). Inhibition of fibroblast growth factors by green tea. International Journal of Oncology. 21(3). 487–91. 39 indexed citations

15.

DiFronzo, L. Andrew, Leslie A. Wanek, Robert Elashoff, & Donald L. Morton. (1999). Increased Incidence of Second Primary Melanoma in Patients With a Previous Cutaneous Melanoma. Annals of Surgical Oncology. 6(7). 705–711. 90 indexed citations

16.

Nishikubo, Carol Y., Lori Kunkel, Robert A. Figlin, et al.. (1996). An association between renal cell carcinoma and lymphoid malignancies: A case series of eight patients. Cancer. 78(11). 2421–2426. 38 indexed citations

17.

Miles, Steven A., Han Wang, Robert Elashoff, & Ronald T. Mitsuyasu. (1994). Improved survival for patients with AIDS-related Kaposi's sarcoma.. Journal of Clinical Oncology. 12(9). 1910–1916. 31 indexed citations

18.

DiMatteo, M. Robin, Ron D. Hays, Ellen R. Gritz, et al.. (1993). Patient adherence to cancer control regimens: Scale development and initial validation.. Psychological Assessment. 5(1). 102–112. 143 indexed citations

19.

Gritz, Ellen R., Rosane Nisenbaum, Robert Elashoff, & E. Carmack Holmes. (1991). Smoking behavior following diagnosis in patients with Stage I non-small cell lung cancer. Cancer Causes & Control. 2(2). 105–112. 114 indexed citations

20.

Champlin, Richard E., Robert Elashoff, Andrew Jacobs, et al.. (1984). PROLONGED SURVIVAL IN ACUTE MYELOGENOUS LEUKAEMIA WITHOUT MAINTENANCE CHEMOTHERAPY. The Lancet. 323(8382). 894–896. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact